Literature DB >> 19752355

Significant changes in mitral valve leaflet matrix composition and turnover with tachycardia-induced cardiomyopathy.

Elizabeth H Stephens1, Tomasz A Timek, George T Daughters, Joyce J Kuo, Aaron M Patton, L Scott Baggett, Neil B Ingels, D Craig Miller, K Jane Grande-Allen.   

Abstract

BACKGROUND: Dilated cardiomyopathy (DCM) involves significant remodeling of the left ventricular-mitral valve (MV) complex, but little is known regarding the remodeling of the mitral leaflets. The aim of this study was to assess changes in matrix composition and turnover in MV leaflets with DCM. METHODS AND
RESULTS: Radiopaque markers were implanted in 24 sheep to delineate the MV; 10 sheep underwent tachycardia-induced cardiomyopathy (TIC), whereas 14 sheep remained as controls. Biplane videofluoroscopy was performed before and after TIC. Immunohistochemistry was performed on leaflet cross-sections taken from the septal, lateral, anterior, and posterior commissures attachment segments. Staining intensity was quantified within each attachment segment and leaflet region (basal, mid-leaflet, and free edge). Mitral regurgitation increased from 0.2+/-0.4 before TIC to 2.2+/-0.9 after TIC (P<0.0002). TIC leaflets demonstrated significant remodeling compared to controls, including greater cell density and loss of leaflet layered structure (all P<0.05). Collagen and elastic fiber turnover was greater in TIC, as was the myofibroblast phenotype (all P<0.05). Compositional differences between TIC and control leaflets were heterogeneous by annular segment and leaflet region, and related to regional changes in leaflet segment length with TIC.
CONCLUSIONS: This study shows that the MV leaflets are significantly remodeled in DCM with changes in leaflet composition, structure, and valve cell phenotype. Understanding how alterations in leaflet mechanics, such as those induced by DCM, drive cell-mediated remodeling of the extracellular matrix will be important in developing future treatment strategies.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19752355      PMCID: PMC2863305          DOI: 10.1161/CIRCULATIONAHA.108.844159

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  26 in total

1.  Micromechanics of the fibrosa and the ventricularis in aortic valve leaflets.

Authors:  I Vesely; R Noseworthy
Journal:  J Biomech       Date:  1992-01       Impact factor: 2.712

2.  Activated interstitial myofibroblasts express catabolic enzymes and mediate matrix remodeling in myxomatous heart valves.

Authors:  E Rabkin; M Aikawa; J R Stone; Y Fukumoto; P Libby; F J Schoen
Journal:  Circulation       Date:  2001-11-20       Impact factor: 29.690

3.  Color Doppler assessment of mitral regurgitation with orthogonal planes.

Authors:  F Helmcke; N C Nanda; M C Hsiung; B Soto; C K Adey; R G Goyal; R P Gatewood
Journal:  Circulation       Date:  1987-01       Impact factor: 29.690

4.  Differential collagen distribution in the mitral valve and its influence on biomechanical behaviour.

Authors:  K S Kunzelman; R P Cochran; S S Murphree; W S Ring; E D Verrier; R C Eberhart
Journal:  J Heart Valve Dis       Date:  1993-03

5.  Tachycardia-induced cardiomyopathy in the ovine heart: mitral annular dynamic three-dimensional geometry.

Authors:  Tomasz A Timek; Paul Dagum; David T Lai; David Liang; George T Daughters; Frederick Tibayan; Neil B Ingels; D Craig Miller
Journal:  J Thorac Cardiovasc Surg       Date:  2003-02       Impact factor: 5.209

6.  Size and motion of the mitral valve annulus in man. II. Abnormalities in mitral valve prolapse.

Authors:  J A Ormiston; P M Shah; C Tei; M Wong
Journal:  Circulation       Date:  1982-04       Impact factor: 29.690

7.  Structural alterations in heart valves during left ventricular pressure overload in the rat.

Authors:  I E Willems; M G Havenith; J F Smits; M J Daemen
Journal:  Lab Invest       Date:  1994-07       Impact factor: 5.662

8.  Dynamics of mitral regurgitant flow and orifice area. Physiologic application of the proximal flow convergence method: clinical data and experimental testing.

Authors:  E Schwammenthal; C Chen; F Benning; M Block; G Breithardt; R A Levine
Journal:  Circulation       Date:  1994-07       Impact factor: 29.690

9.  The renin-angiotensin-aldosterone system, antidiuretic hormone and sympathetic nerve activity in an experimental model of congestive heart failure in the dog.

Authors:  A J Riegger; G Liebau
Journal:  Clin Sci (Lond)       Date:  1982-05       Impact factor: 6.124

10.  Experimental congestive heart failure produced by rapid ventricular pacing in the dog: cardiac effects.

Authors:  J R Wilson; P Douglas; W F Hickey; V Lanoce; N Ferraro; A Muhammad; N Reichek
Journal:  Circulation       Date:  1987-04       Impact factor: 29.690

View more
  20 in total

1.  Perinatal changes in mitral and aortic valve structure and composition.

Authors:  Elizabeth H Stephens; Allison D Post; Daniel R Laucirica; K Jane Grande-Allen
Journal:  Pediatr Dev Pathol       Date:  2010-06-10

Review 2.  Mitral valve disease--morphology and mechanisms.

Authors:  Robert A Levine; Albert A Hagége; Daniel P Judge; Muralidhar Padala; Jacob P Dal-Bianco; Elena Aikawa; Jonathan Beaudoin; Joyce Bischoff; Nabila Bouatia-Naji; Patrick Bruneval; Jonathan T Butcher; Alain Carpentier; Miguel Chaput; Adrian H Chester; Catherine Clusel; Francesca N Delling; Harry C Dietz; Christian Dina; Ronen Durst; Leticia Fernandez-Friera; Mark D Handschumacher; Morten O Jensen; Xavier P Jeunemaitre; Hervé Le Marec; Thierry Le Tourneau; Roger R Markwald; Jean Mérot; Emmanuel Messas; David P Milan; Tui Neri; Russell A Norris; David Peal; Maelle Perrocheau; Vincent Probst; Michael Pucéat; Nadia Rosenthal; Jorge Solis; Jean-Jacques Schott; Ehud Schwammenthal; Susan A Slaugenhaupt; Jae-Kwan Song; Magdi H Yacoub
Journal:  Nat Rev Cardiol       Date:  2015-10-20       Impact factor: 32.419

3.  A detailed mechanical and microstructural analysis of ovine tricuspid valve leaflets.

Authors:  William D Meador; Mrudang Mathur; Gabriella P Sugerman; Tomasz Jazwiec; Marcin Malinowski; Matthew R Bersi; Tomasz A Timek; Manuel K Rausch
Journal:  Acta Biomater       Date:  2019-11-22       Impact factor: 8.947

Review 4.  Basic mechanisms of mitral regurgitation.

Authors:  Jacob P Dal-Bianco; Jonathan Beaudoin; Mark D Handschumacher; Robert A Levine
Journal:  Can J Cardiol       Date:  2014-07-02       Impact factor: 5.223

Review 5.  Cellular mechanisms in mitral valve disease.

Authors:  Kareem Salhiyyah; Magdi H Yacoub; Adrian H Chester
Journal:  J Cardiovasc Transl Res       Date:  2011-09-03       Impact factor: 4.132

Review 6.  Heart Valve Biomechanics and Underlying Mechanobiology.

Authors:  Salma Ayoub; Giovanni Ferrari; Robert C Gorman; Joseph H Gorman; Frederick J Schoen; Michael S Sacks
Journal:  Compr Physiol       Date:  2016-09-15       Impact factor: 9.090

Review 7.  Insight into pathologic abnormalities in congenital semilunar valve disease based on advances in understanding normal valve microstructure and extracellular matrix.

Authors:  Elizabeth H Stephens; Debra L Kearney; K Jane Grande-Allen
Journal:  Cardiovasc Pathol       Date:  2011-02-23       Impact factor: 2.185

8.  Regulation of valve interstitial cell homeostasis by mechanical deformation: implications for heart valve disease and surgical repair.

Authors:  Salma Ayoub; Chung-Hao Lee; Kathryn H Driesbaugh; Wanda Anselmo; Connor T Hughes; Giovanni Ferrari; Robert C Gorman; Joseph H Gorman; Michael S Sacks
Journal:  J R Soc Interface       Date:  2017-10       Impact factor: 4.118

Review 9.  The heterogeneous biomechanics and mechanobiology of the mitral valve: implications for tissue engineering.

Authors:  K Jane Grande-Allen; Jun Liao
Journal:  Curr Cardiol Rep       Date:  2011-04       Impact factor: 2.931

10.  Regurgitation Hemodynamics Alone Cause Mitral Valve Remodeling Characteristic of Clinical Disease States In Vitro.

Authors:  Patrick S Connell; Anam F Azimuddin; Seulgi E Kim; Fernando Ramirez; Matthew S Jackson; Stephen H Little; K Jane Grande-Allen
Journal:  Ann Biomed Eng       Date:  2015-07-30       Impact factor: 3.934

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.